Showing results (21-30 of 175) with videos related to
Sort By:
Pageof 18
The Tohoku Journal of Experimental Medicine|March 10, 2015
Efficient screening strategy for Lynch syndrome in Japanese endometrial cancerTae Sugawara, Naoki Sato, Dai Shimizu, et al.Annals of Surgical Oncology|April 5, 2020
Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic EsophagusMitsuro Kanda, Masahiko Koike, Dai Shimizu, et al.Journal of Gastroenterology|June 21, 2022
Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapyHaruyoshi Tanaka, Mitsuro Kanda, Dai Shimizu, et al.Cancer Chemotherapy and Pharmacology|October 29, 2023
Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancerYao Liang, Osamu Maeda, Kazushi Miyata, et al.Molecular Therapy. Nucleic Acids|November 24, 2020
Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric CancerMitsuro Kanda, Yuuya Kasahara, Dai Shimizu, et al.Surgery Today|March 18, 2021
Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancerMasahiro Shibata, Takahiro Inaishi, Takahiro Ichikawa, et al.Annals of Surgical Oncology|November 13, 2021
SLC7A9 as a Potential Biomarker for Lymph Node Metastasis of Esophageal Squamous Cell CarcinomaHayato Baba, Mitsuro Kanda, Koichi Sawaki, et al.Cancer Genomics & Proteomics|July 7, 2018
Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric CancerDai Shimizu, Tomoko Saito, Shuhei Ito, et al.Anticancer Research|January 31, 2021
Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric CancerMasahiro Sasahara, Mitsuro Kanda, Dai Shimizu, et al.Annals of Surgical Oncology|April 6, 2022
Prognostic Value of a Modified Albumin-Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical ResectionTakahiro Shinozuka, Mitsuro Kanda, Dai Shimizu, et al.Pageof 18